Spots Global Cancer Trial Database for synovitis
Every month we try and update this database with for synovitis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) | NCT05417789 | TGCT | Emactuzumab Placebo | 12 Years - | SynOx Therapeutics Limited | |
Evaluation of the Effectiveness of Surgical Treatment of Villo-nodular Synovitis of the Hip in Children | NCT03507933 | Synovitis | 10 Years - 18 Years | Lille Catholic University | ||
A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor | NCT02673736 | Solid Tumors Tenosynovial Gi... Synovitis, Pigm... | PLX73086 | 18 Years - | Plexxikon | |
A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor | NCT02673736 | Solid Tumors Tenosynovial Gi... Synovitis, Pigm... | PLX73086 | 18 Years - | Plexxikon | |
Evaluation of the Effectiveness of Surgical Treatment of Villo-nodular Synovitis of the Hip in Children | NCT03507933 | Synovitis | 10 Years - 18 Years | Lille Catholic University | ||
Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) | NCT05417789 | TGCT | Emactuzumab Placebo | 12 Years - | SynOx Therapeutics Limited |